Advertisement

Long-Term Treatment with Thiazide in the Prevention of Calcium Nephrolithiasis

  • N. Tessitore
  • A. D’Angelo
  • F. Pagano
  • C. Lo Schiavo
  • A. Corgnati
  • A. Fabris
  • A. Lupo
  • E. Valvo
  • A. Tasca
  • L. Oldrizzi
  • G. Previato
  • G. Maschio
Part of the Ettore Majorana International Science Series book series (EMISS, volume 9)

Abstract

During the last 4 years, we have examined 292 patients with recurrent calcium nephrolithiasis. During 1845 years of lithiasis, they had formed 2340 stones, with a mean interval between two stone events of about 9 months. Hypercalciuria was observed in 56%, and hyperuricosuria in 22% of the patients.

A reliable follow-up after thiazide administration (hydrochlorothiazide 50 mg + amiloride 5 mg per day) was obtained in 161 patients, treated for 4–48 months (mean 18 months). During the treatment, 15 new stones were formed, in contrast with the 305 predicted. In our experience, thiazide (associated with allopurinol in patients with hyperuricosuria) is very effective in preventing the recurrences of calcium nephrolithiasis.

Keywords

Calcium Excretion Urinary Calcium Excretion Idiopathic Hypercalciuria Serum Uric Acid Concentration Urinary Magnesium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aroldi, A., Graziani, G., Mioni, G., Cecchettin, M., Brancaccio, D., Galmozzi, C., Surian, M., Cantaluppi, A. and Ponticelli, C.: Thiazide diuretics in renal hypercalciuria. Proc. EDTA 16: 571–576, (1979).Google Scholar
  2. 2.
    Coe, F.L.: Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyper- uricosuria and no metabolic disorders. Ann. Int. Med. 87: 404–410, (1977).Google Scholar
  3. 3.
    Coe, F.L.: Nephrolithiasis. Pathogenesis and Treatment. Year Book Publ. Chicago, (1978).Google Scholar
  4. 4.
    Hodgkinson, A. and Pyrah, L.N.: The urinary excretion of calcium and inorganic phosphate in 334 patients with calcium stones of renal origin, Brit. J. Surg. 46: 10–16, (1958).CrossRefGoogle Scholar
  5. 5.
    Pak, C.Y.C., Ohata, M., Lawrence, E.C. and Snyder, W.: The hypercalciurias, Causes, parathyroid function and diagnostic criteria. J. Clin. Inv. 54: 387–399, (1974).CrossRefGoogle Scholar
  6. 6.
    Pak, C.Y.C., Kaplan, R., Bone, H., Townsend, J. and Waters, O.: A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N. Engl. J. Med. 292: 497–500, (1975).CrossRefGoogle Scholar
  7. 7.
    Yendt, E.R., and Cohamin, M.: Prevention of calcium stones with thiazide. Kidney Internat, 13: 397–409, (1978).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • N. Tessitore
    • 1
    • 2
    • 3
    • 4
  • A. D’Angelo
    • 1
    • 2
    • 3
    • 4
  • F. Pagano
    • 1
    • 2
    • 3
    • 4
  • C. Lo Schiavo
    • 1
    • 2
    • 3
    • 4
  • A. Corgnati
    • 1
    • 2
    • 3
    • 4
  • A. Fabris
    • 1
    • 2
    • 3
    • 4
  • A. Lupo
    • 1
    • 2
    • 3
    • 4
  • E. Valvo
    • 1
    • 2
    • 3
    • 4
  • A. Tasca
    • 1
    • 2
    • 3
    • 4
  • L. Oldrizzi
    • 1
    • 2
    • 3
    • 4
  • G. Previato
    • 1
    • 2
    • 3
    • 4
  • G. Maschio
    • 1
    • 2
    • 3
    • 4
  1. 1.Cattedra e Divisione di NefrologiaIstituti OspedalieriVeronaItaly
  2. 2.I Clinica MedicaUniversità di PadovaItaly
  3. 3.Clinica UrologicaUniversita di PadovaItaly
  4. 4.Cattedra di Chimica e Microscopia ClinicaUniversita di Padovasede di VeronaItaly

Personalised recommendations